Myopathy
0
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
1 programInvestigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein MyopathyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
MyolexElectrical Impedance Myography
PhilipsNocturnal ventilation
Human BioSciencesInvestigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy
Clinical Trials (3)
Total enrollment: 184 patients across 3 trials
Muscle Health Measurements Using Electrical Impedance Myography
Start: Apr 2025Est. completion: Sep 2027150 patients
N/ARecruiting
Efficacy and Tolerance of AVAPS Mode in Myotonic Dystrophy
Start: Jul 2012Est. completion: May 201632 patients
N/ACompleted
NCT01547767Human BioSciencesInvestigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy
Start: Feb 2012Est. completion: Mar 20212 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 184 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.